Announcement
AI molecule design could expand the range of treatable diseases
Isomorphic Labs says 85% of proteins linked to human disease were once deemed intractable; their shapes and functions made them less suitable for traditional chemical screening.
TLDR
Isomorphic Labs says AI generative design has opened up the potential to design molecules with atomic precision for disease-linked protein targets once deemed intractable. The company says this shift from experimental screening could expand the number of diseases that can be treated.
Combined views
—
1 Source, first seen ago
